Journal of the National Cancer Institute Advance Access originally published online on October 7, 2008
JNCI Journal of the National Cancer Institute 2008 100(20):1482; doi:10.1093/jnci/djn312
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author 2008. Published by Oxford University Press.
CORRESPONDENCE |
Response: Re: Randomized Controlled Trial to Evaluate Transdermal Testosterone in Female Cancer Survivors With Decreased Libido: North Central Cancer Treatment Group Protocol N02C3
Affiliations of authors: Department of Medical Oncology (DLB, CLL) and Department of Cancer Statistics (JAS, RQ), Mayo Clinic College of Medicine, Mayo Clinic, Rochester, MN
Correspondence to: Debra L. Barton, RN, PhD, AOCN, Department of Oncology, Mayo Clinic College of Medicine, Mayo Clinic, 200 First St. SW, Rochester, MN 55905 (e-mail: barton.debra@mayo.edu).
| The first 10% of the full text of this article appears below. |
We appreciate the opportunity to respond to this correspondence. As stated in the statistical methods section of our
Related Correspondence
![]()
CiteULike
Connotea
Del.icio.us What's this?
J Natl Cancer Inst 2008 100: 1482.